The Effectiveness of Idazoxan in Treating TRD

D-cycloserine for Major Depressive Disorder

NCT00408031 ·Status: COMPLETED ·Phase: PHASE2

Treatment of Mild and Subthreshold Depressive Disorders

NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

NCT04532749 ·Status: TERMINATED ·Phase: PHASE3

Efficacy of Statins Among Major Depressive Disorder

NCT06698666 ·Status: RECRUITING ·Phase: PHASE3

Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms

NCT00169988 ·Status: COMPLETED ·Phase: NA

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

NCT04533529 ·Status: COMPLETED ·Phase: PHASE3

Tracking Response to Antidepressants in Advance of Investigational Trials

NCT04748276 ·Status: UNKNOWN

Repetitive Behavior Disorders in People With Severe Mental Retardation

NCT00491478 ·Status: UNKNOWN ·Phase: PHASE3

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

NCT06559306 ·Status: RECRUITING ·Phase: PHASE3

Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.

NCT00158990 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Tolerability of Riluzole in Treatment Resistant Depression

NCT01204918 ·Status: COMPLETED ·Phase: PHASE2

Intensive Accelerated iTBS for the Treatment-Resistant Depression

NCT06166082 ·Status: COMPLETED ·Phase: NA

A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder

NCT04451187 ·Status: COMPLETED ·Phase: PHASE1

The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD

NCT02473783 ·Status: COMPLETED ·Phase: PHASE2

A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)

NCT00275197 ·Status: COMPLETED ·Phase: PHASE2

The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram

NCT00179257 ·Status: COMPLETED ·Phase: PHASE3

Study of 6(S)-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive Disorder

NCT00955955 ·Status: COMPLETED ·Phase: PHASE4

Tracking Response to Antidepressants in Advance of Investigational Trials, Relapse Study

NCT04933630 ·Status: COMPLETED

A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients

NCT01607593 ·Status: COMPLETED

Strategic Use of New Generation Antidepressants for Depression

NCT01109693 ·Status: COMPLETED ·Phase: PHASE4

TRIAD - Treatment of Insomnia and Depression

NCT00767624 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome

NCT00149825 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder

NCT04975100 ·Status: COMPLETED ·Phase: PHASE4

The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder

NCT01418638 ·Status: UNKNOWN

Creatine as a New Therapeutic Strategy in Depression

NCT00313417 ·Status: TERMINATED ·Phase: PHASE4